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Summary box
 ► The current WHO independent high- level commis-
sion on non- communicable diseases’ report lacks 
clear focus on addressing the issues of inequalities 
in non- communicable diseases.
 ► Much stronger recommendations are needed to en-
sure appropriate investment in strengthening and 
improving the quality of health systems, especially 
at primary healthcare.
 ► Governments, the private sector and other actors all 
need to be involved in finding sustainable solutions 
to ensure access to medicines and technologies for 
non- communicable diseases.
 ► Non- communicable diseases in humanitarian emer-
gencies need to be included in any global guidance 
on the issue.
 ► In all contexts allocation of resources needs to op-
timise access for long- term care and treatment, 
paired with population- wide prevention efforts in 
order to guarantee universal health coverage.
On 10 December 2019, the WHO launched the 
‘It’s time to walk the talk: WHO independent 
high- level commission on non- communicable 
diseases’ report.1 This was the second report 
of the commission convened in 2017 by the 
director general of the WHO to address the 
global burden of non- communicable diseases 
(NCDs) in innovative ways. The current 
report highlights that given the current 
measures in place the 2030 sustainable devel-
opment goal (SDG) target 3.4 of reducing 
by ‘one third premature mortality from non- 
communicable diseases through prevention 
and treatment and promote mental health 
and well- being’ will not be met.2 Whereas the 
first report proposed recommendations for 
heads of state, governments, civil society and 
the private sector, the proposals put forward 
in this report were targeted at the WHO. The 
eight recommendations include: encour-
aging heads of state and governments to take 
the lead in the NCD response; supporting 
countries to ensure healthy lifestyles for their 
populations; proposing investments in mental 
health; including prevention in universal 
health coverage (UHC); introducing social 
and financial protection measures to prevent 
people falling into poverty due to NCDs; 
engaging with businesses and member states 
to address NCDs and mental health; encour-
aging interactions between governments and 
civil society; and advocating for a ‘multi- donor 
trust fund to support countries in activities to 
reduce NCDs and promote mental health’.3
As a group of humanitarian actors, clinicians 
and academics active in the area of NCDs in 
low/middle- income countries (LMICs) and 
humanitarian settings, we welcome the launch 
of this report. The report rightly addresses 
many of the determinants driving the NCD 
epidemic and offers concrete actions for the 
WHO to move progress forward with govern-
ments, civil society and the private sector.
However, we feel that the important 
concept of inequality is largely missing from 
the report. By inequality we refer to the 
disparities in access to healthcare and services 
which are ‘unnecessary’, ‘avoidable’ and 
‘unfair and unjust’.4 This is essential to align 
with the SDG 2030 agenda of ‘leaving no one 
behind’,5 also quoted in the report.1 We see 
three components that are essential to tack-
ling the inequalities that exist for NCDs: func-
tioning and fully supported health systems, 
access to medicines and technologies and 
addressing NCDs in humanitarian settings.
Although the report does mention health 
systems and provides a focus on primary 
healthcare (PHC), much stronger recom-
mendations are needed to ensure appropriate 
investment in strengthening and improving 
the quality of health systems, especially at 
PHC level.6 To date, PHC is not equipped in 
many settings to address the needs of popula-
tions in managing NCDs and to do this strong 
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government involvement and investment are required.7 8 
This also needs to be supported by the global community 
as a priority. Beyond this, a shift in paradigm is needed, 
focusing on how health systems respond to the complex 
needs of the populations they serve,6 especially those with 
NCDs. This focus on health systems does not preclude 
active support to essential population- wide preven-
tion strategies. On the contrary, it will reinforce these 
by having prevention measures tailored to the context 
where people live.9
With regards to access to medicines and technologies, 
including diagnostic tools, many studies have found that 
availability and affordability of NCD medicines and tech-
nologies is much lower in LMICs than in high- income 
countries (HICs).10 Insulin is a striking example in that 
despite having been discovered 100 years, there are 
marked disparities and gaps in global insulin access.11 
Governments, the private sector and other actors all need 
to be involved in finding sustainable solutions to ensure 
access to medicines and technologies within functioning 
health systems.
Lastly, as the report acknowledges, it fails to contextu-
alise NCDs in humanitarian settings. Currently, the world 
is seeing an unprecedented number of individuals facing 
humanitarian emergencies with 125 million people 
affected,12 almost equivalent to the population of Japan. 
These individuals face many barriers to accessing care 
and medicines and are often reliant on external inter-
ventions to ensure their survival. Many of the authors of 
this comment are involved in a working group that estab-
lishes principles and guidelines for the management of 
NCDs in humanitarian settings, which have only recently 
started to be addressed in a systematic way.
Despite high- level meetings at the United Nations, the 
WHO’s global action plan for the prevention and control 
of non- communicable diseases and two reports from the 
high- level commission on NCDs, the global NCD response 
has failed to materialise. There are some positive tangible 
results, such as a renewed call for the importance of PHC 
during the 40th Anniversary of the Alma- Ata Declaration, 
plans for inclusion of insulin in the WHO’s prequalifi-
cation programme and the WHO’s development of an 
emergency health kit of key NCD medicines and tech-
nologies, which all help address inequalities on the NCD 
agenda.
For NCDs, embracing prevention, addressing risk 
factors and improving access to care require different 
approaches and policies.13 Addressing risk factors 
requires strong policies, multi- sectoral involvement and 
global conventions and guidance as has been devel-
oped for tobacco. For provision of care, a solid health 
system response needs to be locally driven with a focus 
on national and subnational policies. Globally, in HICs, 
LMICs and humanitarian settings, the delivery of chronic 
care needs to adapt to the complexity of managing NCDs 
and their associated multi- morbidities, with a focus on 
PHC and involvement of local communities, as one 
size does not fit all. This is even more relevant given 
the current COVID-19 pandemic as people with NCDs 
are more vulnerable and need resilient health systems 
providing population- wide prevention, continuous 
access to care and referrals. While the pandemic’s conse-
quences are truly global, people with NCDs in countries 
affected by humanitarian crises with overcrowded camps, 
places of detention and communities that are already 
highly vulnerable, where health and other systems are 
weak and under- resourced, will bear the brunt of the 
current and future impact of the pandemic. COVID-19 
will exacerbate existing inequalities and possibly create 
new ones given the wide social and economic challenges 
that the pandemic has created and people with NCDs will 
be among those most vulnerable to these inequalities.
In all contexts allocation of resources needs to opti-
mise access for long- term care and treatment, paired 
with population- wide prevention efforts in order to guar-
antee UHC. The UHC agenda places strong emphasis 
on equality in access to services, medicines, including in 
humanitarian settings. While the report invites us ‘to walk 
the talk’ proposing ‘bold’ recommendations, for polit-
ical commitment on NCDs we contend that these could 
have been stronger to also address inequalities in access 
to NCD care and medicines for the millions of people 
already with NCDs.14 Any recommendation for NCDs 
must guarantee equal access to NCD prevention, treat-
ment, care and rehabilitation for all in need, in order to 
truly leave no one behind.
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